Priority Date: 11.06.12 (GB 20120010226)

GENETICALLY MODIFIED SCHMALLENBERG VIRUS (SBV) FOR USE AS VACCINE

  • Application ID: EP13729797
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This patent has the IPC combination A01, A61, and C12 is specialized in the combination A01, A61, and C12. We found, that Sperling Fischer & Heyner, Zacco Denmark A/S, Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB and 33 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 11.06.2012 - Priority Date (GB 20120010226)
  • 19.12.2013 - Publication A1 (WO2013186539)
  • 15.04.2015 - Publication A1 (EP2859094)

IPC Classification